Literature DB >> 19564576

Epac inhibits apoptosis of human leukocytes.

M Grandoch1, V Bujok, D Fleckenstein, M Schmidt, J W Fischer, A-A Weber.   

Abstract

cAMP is known to participate in the regulation of apoptosis in leukocytes. Depending on the cell type, pro- and antiapoptotic effects of cAMP have been described. Thus far, most of the cAMP-dependent effects have been attributed to the activation of PKA. However, Epac proteins (direct cAMP targets and guanine nucleotide exchange factors for Ras-like GTPases) have been shown recently to contribute to cAMP-dependent regulation of apoptosis. Therefore, we investigated the effects of the selective Epac activators 8-pCPT and Sp on apoptosis in human leukocytic cells (U937, HL-60, primary human mononuclear cells). We report here that Epac activation inhibits leukocyte apoptosis significantly.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19564576     DOI: 10.1189/jlb.0109048

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  8 in total

Review 1.  cAMP guided his way: a life for G protein-mediated signal transduction and molecular pharmacology-tribute to Karl H. Jakobs.

Authors:  Klaus Aktories; Peter Gierschik; Dagmar Meyer Zu Heringdorf; Martina Schmidt; Günter Schultz; Thomas Wieland
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2019-05-17       Impact factor: 3.000

Review 2.  Cyclic AMP is both a pro-apoptotic and anti-apoptotic second messenger.

Authors:  P A Insel; L Zhang; F Murray; H Yokouchi; A C Zambon
Journal:  Acta Physiol (Oxf)       Date:  2011-05-26       Impact factor: 6.311

3.  Differential roles of Epac in regulating cell death in neuronal and myocardial cells.

Authors:  Sayaka Suzuki; Utako Yokoyama; Takaya Abe; Hiroshi Kiyonari; Naoya Yamashita; Yuko Kato; Reiko Kurotani; Motohiko Sato; Satoshi Okumura; Yoshihiro Ishikawa
Journal:  J Biol Chem       Date:  2010-06-01       Impact factor: 5.157

Review 4.  The role of Epac proteins, novel cAMP mediators, in the regulation of immune, lung and neuronal function.

Authors:  Maria Grandoch; Sara S Roscioni; Martina Schmidt
Journal:  Br J Pharmacol       Date:  2009-11-11       Impact factor: 8.739

5.  Inhibition of the hyaluronan matrix enhances metabolic anticancer therapy by dichloroacetate in vitro and in vivo.

Authors:  Sören Twarock; Christina Reichert; Katharina Bach; Oliver Reiners; Inga Kretschmer; Daniel J Gorski; Katharina Gorges; Maria Grandoch; Jens W Fischer
Journal:  Br J Pharmacol       Date:  2019-12-09       Impact factor: 8.739

6.  Reprogrammed mRNA translation drives resistance to therapeutic targeting of ribosome biogenesis.

Authors:  Katherine M Hannan; Jian Kang; Richard B Pearson; Eric P Kusnadi; Anna S Trigos; Carleen Cullinane; David L Goode; Ola Larsson; Jennifer R Devlin; Keefe T Chan; David P De Souza; Malcolm J McConville; Grant A McArthur; George Thomas; Elaine Sanij; Gretchen Poortinga; Ross D Hannan
Journal:  EMBO J       Date:  2020-09-18       Impact factor: 11.598

7.  Elevation of cAMP Levels Inhibits Doxorubicin-Induced Apoptosis in Pre- B ALL NALM- 6 Cells Through Induction of BAD Phosphorylation and Inhibition of P53 Accumulation.

Authors:  Ahmad Fatemi; Ahmad Kazemi; Meysam Kashiri; Majid Safa
Journal:  Int J Mol Cell Med       Date:  2015

8.  Forskolin Sensitizes Human Acute Myeloid Leukemia Cells to H3K27me2/3 Demethylases GSKJ4 Inhibitor via Protein Kinase A.

Authors:  Michela Illiano; Mariarosaria Conte; Luigi Sapio; Angela Nebbioso; Annamaria Spina; Lucia Altucci; Silvio Naviglio
Journal:  Front Pharmacol       Date:  2018-07-20       Impact factor: 5.810

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.